For research use only. Not for therapeutic Use.
BAY-474(CAT: I017359) is a selective tyrosine-protein kinase c-Met inhibitor with potential applications in cancer and epigenetics research. By targeting the c-Met signaling pathway, BAY-474 disrupts cellular processes such as proliferation, migration, and survival that are often dysregulated in tumors. In addition to its kinase inhibitory activity, BAY-474 functions as an epigenetics probe, making it valuable for exploring the interplay between oncogenic signaling and epigenetic regulation. This dual activity provides a unique platform for investigating tumor progression, resistance mechanisms, and therapeutic strategies. BAY-474 serves as a versatile research tool in cancer biology, targeted therapy development, and epigenetics.
| CAS Number | 1033767-86-0 |
| Synonyms | 2,6-dimethyl-4-(3-methyl-2H-indazol-5-yl)-1,4-dihydropyridine-3,5-dicarbonitrile |
| Molecular Formula | C17H15N5 |
| Purity | ≥95% |
| IUPAC Name | 2,6-dimethyl-4-(3-methyl-2H-indazol-5-yl)-1,4-dihydropyridine-3,5-dicarbonitrile |
| InChI | InChI=1S/C17H15N5/c1-9-14(7-18)17(15(8-19)10(2)20-9)12-4-5-16-13(6-12)11(3)21-22-16/h4-6,17,20H,1-3H3,(H,21,22) |
| InChIKey | QKVFMAAIXZONRN-UHFFFAOYSA-N |
| SMILES | CC1=C2C=C(C=CC2=NN1)C3C(=C(NC(=C3C#N)C)C)C#N |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
